<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04705324</url>
  </required_header>
  <id_info>
    <org_study_id>0087-20-TLV</org_study_id>
    <nct_id>NCT04705324</nct_id>
  </id_info>
  <brief_title>Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion</brief_title>
  <official_title>Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomizedtrial comparing success and complication rates of operative hysteroscopy versus&#xD;
      traditional dilation and curettage (D&amp;C) in the management of first trimester missed&#xD;
      abortion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled trial (RCT) of women diagnosed with first trimester spontaneous&#xD;
      abortion. Participants interested in operative evacuation of the uterus will be randomized to&#xD;
      either operative hysteroscopy or dilation an curettage (D&amp;C). Study population will include&#xD;
      pregnant women diagnosed with first trimester spontaneous abortion of up to 11+0 weeks from&#xD;
      last menstrual period (LMP). Women who will electively choose to terminate their pregnancy as&#xD;
      well as women diagnosed with threatened, incomplete or inevitable abortion will be excluded.&#xD;
      All participants will undergo diagnostic hysteroscopy 6-8 weeks after allocated treatment in&#xD;
      order to rule out intrauterine adhesion formation and retained product of conception. The&#xD;
      primary outcome measure is the risk of intrauterine adhesion formation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 17, 2021</start_date>
  <completion_date type="Anticipated">January 16, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 16, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intrauterine adhesions (IUA)</measure>
    <time_frame>2 months</time_frame>
    <description>IUA formation will be assessed in all participants in the follow up diagnostic hysteroscopy performed 8 weeks after the primary treatment. IUA will be classified according to the American Society for Reproductive Medicine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retained product of conception (RPOC)</measure>
    <time_frame>2 months</time_frame>
    <description>RPOC rate in repeat ultrasound scan performed 8 weeks after primary treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Spontaneous Abortion</condition>
  <condition>Missed Abortion</condition>
  <condition>Intrauterine Adhesion</condition>
  <condition>Retained Products of Conception</condition>
  <arm_group>
    <arm_group_label>Operative Hysteroscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hysteroscopic separation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dilation and Curettage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Curettage separation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Operative Hysteroscopy</intervention_name>
    <description>Separation of the non-viable gestational sac from the uterine wall will through operative hysteroscopy</description>
    <arm_group_label>Operative Hysteroscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>D&amp;C</intervention_name>
    <description>Separation of the non-viable gestational sac from the uterine wall through dilation and curettage</description>
    <arm_group_label>Dilation and Curettage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women diagnosed with missed abortion who choose to undergo surgical evacuation. and&#xD;
             who are at gestational age of 5+0 weeks to 11+0 weeks from last menstrual period&#xD;
             (LMP).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  women who electively choose to terminate pregnancy&#xD;
&#xD;
          -  women who took medical treatment for missed abortion prior to recruitment&#xD;
&#xD;
          -  women with known uterine abnormality&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yossi Tzur</last_name>
    <phone>+97236925603</phone>
    <email>yossitzur@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gilad Rattan</last_name>
    <phone>+97236925603</phone>
    <email>giladrattan@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lis Maternity Hospital, Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>6423906</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yariv Yogev, MD</last_name>
      <phone>97236925603</phone>
      <email>yarivyogev@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yossi Tzur, MD</last_name>
      <phone>97236925603</phone>
      <email>yossitzur@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yogev Yariv, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilad Rattan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yossi Tzur, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000 Jun 24;320(7251):1708-12.</citation>
    <PMID>10864550</PMID>
  </reference>
  <reference>
    <citation>Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril. 2003 Mar;79(3):577-84.</citation>
    <PMID>12620443</PMID>
  </reference>
  <reference>
    <citation>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol. 2018 Nov;132(5):e197-e207. doi: 10.1097/AOG.0000000000002899.</citation>
    <PMID>30157093</PMID>
  </reference>
  <reference>
    <citation>Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM; National Institute of Child Health Human Development (NICHD) Management of Early Pregnancy Failure Trial. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005 Aug 25;353(8):761-9.</citation>
    <PMID>16120856</PMID>
  </reference>
  <reference>
    <citation>Hooker AB, Lemmers M, Thurkow AL, Heymans MW, Opmeer BC, Br√∂lmann HA, Mol BW, Huirne JA. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update. 2014 Mar-Apr;20(2):262-78. doi: 10.1093/humupd/dmt045. Epub 2013 Sep 29. Review.</citation>
    <PMID>24082042</PMID>
  </reference>
  <reference>
    <citation>Salzani A, Yela DA, Gabiatti JR, Bedone AJ, Monteiro IM. Prevalence of uterine synechia after abortion evacuation curettage. Sao Paulo Med J. 2007 Sep 6;125(5):261-4.</citation>
    <PMID>18094891</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 10, 2021</study_first_submitted>
  <study_first_submitted_qc>January 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>January 10, 2021</last_update_submitted>
  <last_update_submitted_qc>January 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>Eli Sprecher, MD</investigator_full_name>
    <investigator_title>Deputy Director Research &amp; Development</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Abortion, Missed</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Study protocol and statistical analysis plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

